OBJECTIVE: Differences in psychiatric distress and substance use (licit and illicit) were examined in methadone maintenance treatment (MMT) patients with a variety of pain experiences. METHOD: Parametric and nonparametric statistical tests were performed on data obtained from 150 patients currently enrolled in MMT. Assessments were carried out at the 3 opioid agonist treatment programs operated by the APT Foundation, New Haven, Connecticut. Participants were recruited between March 2007 and March 2008. RESULTS: In comparison to MMT patients reporting no pain in the previous week, those with chronic severe pain (CSP) (ie, pain lasting at least 6 months with moderate to severe pain intensity or significant pain interference) exhibited significantly higher (P < .01) levels of depression, anxiety, somatization, overall psychiatric distress, and personality disorder criteria but reported comparable rates of substance use. A third group, ie, non-CSP MMT patients reporting some pain in the past week, differed significantly (P < .05) from the other 2 pain groups on somatization and global psychiatric distress but reported comparable rates of substance use. CONCLUSIONS: Pain-related differences in psychiatric problems exist in MMT patients and may have implications for program planning and outreach efforts. Copyright 2009 Physicians Postgraduate Press, Inc.
OBJECTIVE: Differences in psychiatric distress and substance use (licit and illicit) were examined in methadone maintenance treatment (MMT) patients with a variety of pain experiences. METHOD: Parametric and nonparametric statistical tests were performed on data obtained from 150 patients currently enrolled in MMT. Assessments were carried out at the 3 opioid agonist treatment programs operated by the APT Foundation, New Haven, Connecticut. Participants were recruited between March 2007 and March 2008. RESULTS: In comparison to MMTpatients reporting no pain in the previous week, those with chronic severe pain (CSP) (ie, pain lasting at least 6 months with moderate to severe pain intensity or significant pain interference) exhibited significantly higher (P < .01) levels of depression, anxiety, somatization, overall psychiatric distress, and personality disorder criteria but reported comparable rates of substance use. A third group, ie, non-CSP MMTpatients reporting some pain in the past week, differed significantly (P < .05) from the other 2 pain groups on somatization and global psychiatric distress but reported comparable rates of substance use. CONCLUSIONS:Pain-related differences in psychiatric problems exist in MMTpatients and may have implications for program planning and outreach efforts. Copyright 2009 Physicians Postgraduate Press, Inc.
Authors: D R Langbehn; B M Pfohl; S Reynolds; L A Clark; M Battaglia; L Bellodi; R Cadoret; W Grove; P Pilkonis; P Links Journal: J Pers Disord Date: 1999
Authors: Robert Sheu; David Lussier; Andrew Rosenblum; Chunki Fong; Jason Portenoy; Herman Joseph; Russell K Portenoy Journal: Pain Med Date: 2008-03-11 Impact factor: 3.750
Authors: Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Mary Jo Larson; Michael Paasche-Orlow; Debbie M Cheng; Christine Lloyd-Travaglini; Richard Saitz; Jeffrey H Samet Journal: Addiction Date: 2007-05 Impact factor: 6.526
Authors: Barth L Wilsey; Scott M Fishman; Alexander Tsodikov; Christine Ogden; Ingela Symreng; Amy Ernst Journal: Pain Med Date: 2008-02-05 Impact factor: 3.750
Authors: Declan T Barry; Mark Beitel; Christopher J Cutter; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld Journal: J Pain Date: 2010-06-20 Impact factor: 5.820
Authors: Declan T Barry; Mark Beitel; Christopher J Cutter; David A Fiellin; Robert D Kerns; Brent A Moore; Lindsay Oberleitner; Lynn M Madden; Christopher Liong; Joel Ginn; Richard S Schottenfeld Journal: Drug Alcohol Depend Date: 2018-11-13 Impact factor: 4.492
Authors: Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Robert N Jamison; Roger D Weiss Journal: Drug Alcohol Depend Date: 2016-04-25 Impact factor: 4.492
Authors: Judith I Tsui; Marlene C Lira; Debbie M Cheng; Michael R Winter; Daniel P Alford; Jane M Liebschutz; Jianren Mao; Robert R Edwards; Jeffrey H Samet Journal: Drug Alcohol Depend Date: 2015-05-22 Impact factor: 4.492
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Richard S Schottenfeld; Robert D Kerns; Brent A Moore; Lindsay Oberleitner; Michelle T Joy; Nina Keneally; Christopher Liong; Kathleen M Carroll Journal: J Addict Med Date: 2014 Sep-Oct Impact factor: 3.702
Authors: Declan T Barry; Mark Beitel; Christopher J Cutter; Dipa Joshi; Jean Falcioni; Richard S Schottenfeld Journal: J Addict Med Date: 2010-06 Impact factor: 3.702
Authors: Declan T Barry; Christopher J Cutter; Mark Beitel; Robert D Kerns; Christopher Liong; Richard S Schottenfeld Journal: J Clin Psychiatry Date: 2016-10 Impact factor: 4.384
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin Journal: Am J Addict Date: 2013 May-Jun
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin Journal: J Addict Med Date: 2012-12 Impact factor: 3.702